Patent classifications
A
HUMAN NECESSITIES
Load children
A61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
Load children
A61K
PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
Load children
51/00
Preparations containing radioactive substances for use in therapy or testing in vivo
Load children Filter patents View analytics View as hierarchy Open in page
A61K51/02
characterised by the carrier; , i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Load children Filter patents View analytics View as hierarchy Open in page
A61K51/08
Peptides, e.g. proteins; , carriers being peptides, polyamino acids, proteins
Load children Filter patents View analytics View as hierarchy Open in page
A61K51/10
Antibodies or immunoglobulins; Fragments thereof; , the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Load children Filter patents View analytics View as hierarchy Open in page
A61K51/1084
the antibody being a hybrid immunoglobulin
Load children Filter patents View analytics View as hierarchy Open in page

A61K51/1084

Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer
11559583 · 2023-01-24 · ·

Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with one or more immune stimulating agents are provided.

Pharmacokinetic determination of intravitreal agents
09833523 · 2017-12-05 · ·

Compositions and methods for evaluating a pharmacokinetic property of an ophthalmic agent administered by intravitreal injection are provided.

Combination Therapy for Cancer
20200237927 · 2020-07-30 · ·

Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with one or more immune stimulating agents are provided.

HYBRID IMMUNOGLOBULINS WITH MOVING PARTS
20200032272 · 2020-01-30 ·

Hybrid immunoglobulines containing moving parts are provided as well as related compositions and methods of use and methods of production. In addition, analogous genetic devices are provided as well as related compositions and methods of use and methods of production.

Hybrid immunoglobulins with moving parts
10428332 · 2019-10-01 ·

Hybrid immunoglobulins containing moving parts are provided as well as related compositions and methods of use and methods of production. In addition, analogous genetic devices are provided as well as related compositions and methods of use and methods of production.

COMBINATION THERAPY FOR CANCER
20180085472 · 2018-03-29 · ·

Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with one or more immune stimulating agents are provided.

Hybrid immunoglobulins with moving parts
12467053 · 2025-11-11 · ·

Hybrid immunoglobulines containing moving parts are provided as well as related compositions and methods of use and methods of production. In addition, analogous genetic devices are provided as well as related compositions and methods of use and methods of production.